More than 120 Specialist Doctors Participate in the Scientific Program
Kathmandu – A special scientific symposium aimed at addressing the growing challenge of antimicrobial resistance (AMR) to life-saving medicines in Nepal and strengthening the management of critically ill patients was successfully held in Kathmandu.
- Advertisement -
The international symposium on “Antibacterial Resistance and Solutions,” organized by the Nepalese Society of Critical Care, brought together more than 120 specialist doctors from across Nepal. The program featured extensive discussions on the global crisis caused by the irrational and inappropriate use of antibiotics, as well as the current situation and challenges related to antimicrobial resistance in Nepal.
Emphasis on Appropriate Antibiotic Use and Laboratory Testing
Speaking as the keynote speaker, Dr. Sushila Kataria, Vice Chairperson of Medanta Medicity Hospital, India, highlighted the global scenario of antimicrobial resistance and expressed concern over the increasing resistance to life-saving antibiotics in Nepal.
Dr. Kataria emphasized the importance of antibiotic stewardship, stressing that antibiotics should be used only when necessary, at the right time, in the appropriate dose, and for the appropriate duration.
She also advised clinicians to avoid relying solely on empirical assumptions when managing serious infections and to make greater use of necessary laboratory and microbiological investigations, including culture and sensitivity testing, before and during the treatment process whenever clinically appropriate.
Advances in Neurocritical Care
Another distinguished speaker at the program, Dr. Ram E. Rajagopalan, delivered a comprehensive presentation on modern approaches to neurocritical care.
He discussed contemporary procedures, treatment approaches, and strategies for managing complex and life-threatening conditions involving the brain and nervous system, sharing his expertise and experience with the participating physicians.
Focus on Pharmaceutical Manufacturing and Research
During the symposium, Hemant Dawar, Associate Vice President of Gufic Biosciences Ltd., highlighted the company’s 56-year journey in pharmaceutical manufacturing, sharing key experiences and the major factors contributing to its success.
Similarly, Dr. Samveda Samel, Head of Medical Affairs at Gufic Biosciences Ltd., stated that the company is planning to place greater emphasis not only on pharmaceutical manufacturing but also on research, scientific studies, and the publication of evidence-based medical articles in the coming years.
Participants emphasized the need for greater collaboration among clinicians, healthcare institutions, the pharmaceutical industry, and the research community to strengthen critical care services, promote the rational use of antibiotics, and combat antimicrobial resistance in Nepal.
The participating physicians expressed confidence that such scientific and technical programs will serve as an important milestone in advancing critical care medicine, promoting responsible antibiotic use, and preserving the effectiveness of life-saving medicines in Nepal.
प्रतिक्रिया दिनुहोस्